ITEM VIEW

Arrhythmias and COVID-19 infection

dc.contributor.authorChin, Ashleyen_ZA
dc.contributor.authorMoses, Janeen_ZA
dc.contributor.authorThornton, Andrewen_ZA
dc.date.accessioned2021-02-19T13:56:21Z
dc.date.available2021-02-19T13:56:21Z
dc.date.issued2020
dc.identifier.citationChin, A., Moses, J. & Thornton, A. 2020. Arrhythmias and COVID-19 infection. SA Heart, 17(3):362-369, doi:10.24170/17-3-4384
dc.identifier.issn2071-4602 (online)
dc.identifier.issn1996-6741 (print)
dc.identifier.otherdoi:10.24170/17-3-4384
dc.identifier.urihttp://hdl.handle.net/10019.1/109580
dc.descriptionCITATION: Chin, A., Moses, J. & Thornton, A. 2020. Arrhythmias and COVID-19 infection. SA Heart, 17(3):362-369, doi:10.24170/17-3-4384.
dc.descriptionThe original publication is available at http://www.journals.ac.za/index.php/SAHJ
dc.description.abstractArrhythmias can be a clinical manifestation of COVID-19 infection. COVID-19 infection can also be a precipitant of known arrhythmias which can increase the risk of morbidity and mortality. Management of arrhythmias should generally follow standard guidelines of arrhythmia management. Catheter ablation in the midst of the COVID-19 pandemic should be limited to arrhythmias that are immediately life-threatening or which may affect prognosis in the short-term. Some novel treatments like chloroquine, hydroxychloroquine and azithromycin can prolong the QT interval and predispose patients to life-threatening arrhythmias.en_ZA
dc.description.urihttps://www.journals.ac.za/index.php/SAHJ/article/view/4384
dc.format.extent8 pages
dc.language.isoen_ZAen_ZA
dc.publisherSouth African Heart Association
dc.subjectCOVID-19en_ZA
dc.titleArrhythmias and COVID-19 infectionen_ZA
dc.typeArticleen_ZA
dc.description.versionPublisher's version
dc.rights.holderAuthors retain copyright


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

ITEM VIEW